Biliverdin reductase: PKC interaction at the cross-talk of MAPK and PI3K signaling pathways

Antioxidants and Redox Signaling

Volumn 9, Issue 12, 2007, Pages 2187-2195

  Maines, Mahin D ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; BILIRUBIN; BILIVERDIN; BILIVERDIN REDUCTASE; GROWTH FACTOR; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; PROTEIN KINASE C; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME STRUCTURE; GLUCOSE TRANSPORT; HUMAN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; TRANSACTIVATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; PROTEIN KINASE C; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION;

EID: 35848965713     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1805     Document Type: Review

References (73)

1. Ahmad Z, Salim M, and Maines MD. Human biliverdin reductase is a leucine zipper-like DNA-binding protein and functions in transcriptional activation of heme oxygenase-1 by oxidative stress. J Biol Chem 277: 9226-9232, 2002.
2. Awasthi S, Vivekananda J, Awasthi V, Smith D, and King RJ. CTP:phosphocholine cytidylyltransferase inhibition by ceramide via PKC-alpha, p38 MAPK, cPLA2, and 5-lipoxygenase. Am J Physiol Lung Cell Mol Physiol 281: L108-L118, 2001.
3. Backer J, Myers Jr MG, Shoelson SE, Chin DJ, Sun XJ, Miralpeix M, Hu P, Margolis B, Skolnik EY, and Schlessinger J. Phosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J 11: 3469-3479, 1992.
4. Beale SI and Cornejo J. Enzymatic heme oxygenase activity in soluble extracts of the unicellular red alga, Cyanidium caldarium. Arch Biochem Biophys 235: 371-384, 1984.
5. Bell JE and Maines MD. Kinetic properties and regulation of biliverdin reductase. Arch Biochem Biophys 263: 1-9, 1988.
6. Berra E, Diaz-Meco MT, Dominguez I, Municio MM, Sanz L, Lozano J, Chapkin RS, and Moscat J. Protein kinase C zeta isoform is critical for mitogenic signal transduction. Cell 74: 555-563, 1993.
7. Bourbon NA, Yun J, Berkey D, Wang Y, and Kester M. Inhibitory actions of ceramide upon PKC-ε/ERK interactions. Am J Physiol Cell Physiol 280: C1403-C1411, 2001.
8. Cacace AM, Ueffing M, Philipp A, Han EK, Kolch W, and Weinstein IB. PKC e functions as an oncogene by enhancing activation of the Raf kinase. Oncogene 13: 2517-2526, 1996.
9. Cai H, Smola U, Wixler V, Eisenmann-Tappe I, Diaz-Meco MT, Moscat J, Rapp U, and Cooper GM. Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinase. Mol Cell Biol 17: 732-741, 1997.
10. Chalfant CE, Ohno S, Konno Y, Fisher AA, Bisnauth LD, Watson JE, and Cooper DR. A carboxy-terminal deletion mutant of protein kinase C beta II inhibits insulin-stimulated 2-deoxyglucose uptake in L6 rat skeletal muscle cells. Mol Endocrinol 10: 1273-1281, 1996.
11. Chen CC, Sun YT, Chen JJ, and Chang YJ. Tumor necrosis factor-alpha-induced cyclooxygenase-2 expression via sequential activation of ceramide-dependent mitogen-activated protein kinases, and IkappaB kinase 1/2 in human alveolar epithelial cells. Mol Pharmacol 59: 493-500, 2001.
12. Converso DP, Taille C, Carreras MC, Jaitovich A, Poderoso JJ, and Boczkowski J. ho-1 is located in liver mitochondria and modulates mitochondrial heme content and metabolism. FASEB J 20: 1236-1238, 2006.
13. Cote GP, Luo X, Murphy MB, and Egelhoff TT. Mapping of the novel protein kinase catalytic domain of Dictyostelium myosin II heavy chain kinase A. J Biol Chem 272: 6846-6849, 1997.
14. Fakhrai H and Maines MD. Expression and characterization of a cDNA for rat kidney biliverdin reductase: evidence suggesting the liver and kidney enzymes are the same transcript product. J Biol Chem 267: 4023-4029, 1992.
15. Farrar WL and Anderson WB. Interleukin-2 stimulates association of protein kinase C with plasma membrane. Nature 315: 233-235, 1985.
16. Godoy-Ruiz R, Perez-Jimenez R, Ibarra-Molero B, and Sanchez-Ruiz JM. A stability pattern of protein hydrophobic mutations that reflects evolutionary structural optimization. Biophys J 89: 3320-3331, 2005.
17. Gschwendt M, Kittstein W, and Marks F. Protein kinase C activation by phorbol esters: do cysteine-rich regions and pseudosubstrate motifs play a role? Trends Biochem Sci 16: 167-169, 1991.
18. Hanks SK and Hunter T. Protein kinases: the eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J 9: 576-596, 1995.
19. Hanks SK, Quinn AM, and Hunter T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241: 42-52, 1988.
20. Hosseini M, Rose AY, Song K, Bohan C, Alexander JP, Kelley MJ, and Acott TS. IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork. Invest Ophthalmol Vis Sci 47: 1469-1476, 2006.
21. House C and Kemp BE. Protein kinase C contains a pseudosubstrate prototype in its regulatory domain. Science 238: 1726-1728, 1987.
22. Huang TJ, Trakshel GM, and Maines MD. Detection of 10 variants of biliverdin reductase in rat liver by two-dimensional gel electrophoresis. J Biol Chem 264: 7844-7849, 1989.
23. Hunter T. Signaling: 2000 and beyond. Cell 100: 113-127, 2000.
24. Hunter T and Cooper JA. Protein-tyrosine kinases. Annu Rev Biochem 54: 897-930, 1985.
25. Kawakami T, Kawakami Y, and Kitaura J. Protein kinase C beta (PKC beta): normal functions and diseases. J Biochem (Tokyo) 132: 677-682, 2002.
26. Keranen LM, Dutil EM, and Newton AC. Protein kinase C is regulated in vivo by three functionally distinct phosphorylations. Curr Biol 5: 1394-1403, 1995.
27. Kikuchi A, Park SY, Miyatake H, Sun D, Sato M, Yoshida T, and Shiro Y. Crystal structure of rat biliverdin reductase. Nat Struct Biol 8: 221-225, 2001.
28. Knapp LT and Klann E. Superoxide-induced stimulation of protein kinase C via thiol modification and modulation of zinc content. J Biol Chem 275: 24136-24145, 2000.
29. Kohchi T, Mukougawa K, Frankenberg N, Masuda M, Yokota A, and Lagarias JC. The Arabidopsis HY2 gene encodes phytochromobilin synthase, a ferredoxin-dependent biliverdin reductase. Plant Cell 13: 425-436, 2001.
30. Korichneva I, Hoyos B, Chua R, Levi E, and Hammerling U. Zinc release from protein kinase C as the common event during activation by lipid second messenger or reactive oxygen. J Biol Chem 277: 44327-44331, 2002.
31. Kravets A, Hu Z, Miralem T, Torno MD, and Maines MD. Biliverdin reductase: a novel regulator for Induction of activating transcription factor-2 and heme oxygenase-1. J Biol Chem 279: 19916-19923, 2004.
32. Kutty RK and Maines MD. Purification and characterization of biliverdin reductase from rat liver. J Biol Chem 256: 3956-3962, 1981.
33. Lerner-Marmarosh N, Shen J, Torno MD, Kravets A, Hu Z, and Maines MD. Human biliverdin reductase: a member of the insulin receptor substrate family with serine/threonine/tyrosine kinase activity. Proc Natl Acad Sci U S A 102: 7109-7114, 2005.
34. Liu JK, Maria B, Liu Yaping, Lu, Tong; Qu, Wei; Waalkes, Michael P. Stress-related gene expression in mice treated with inorganic arsenicals. Toxicol Sci 61: 314-320, 2001.
35. Maines M. Biliverdin reductase: a reassessment of its functions in the light of recent discoveries. In: Heme Oxygenase in Biology and Medicine: Emergence of the Products Carbon Monoxide, Iron and the Bile Pigments, edited by Otterbein L. Nova Biomedical Books, 2005, pp. 1-36.
36. Maines MD. New insights into biliverdin reductase functions: linking heme metabolism to cell signaling. Physiology (Bethesda) 20: 382-389, 2005.
37. Maines MD, Ewing JF, Huang TJ, and Panahian N. Nuclear localization of biliverdin reductase in the rat kidney: response to nephrotoxins that induce heme oxygenase-1. J Pharmacol Exp Ther 296: 1091-1097, 2001.
38. Maines MD, Miralem T, Lerner-Marmarosh N, Shen J, and Gibbs PE. Human biliverdin reductase: a previously unknown activator of protein kinase C βII. J Biol Chem 282: 8110-8122, 2007.
39. Maines MD, Polevoda BV, Huang TJ, and McCoubrey WK Jr. Human biliverdin IXalpha reductase is a zinc-metalloprotein: characterization of purified and Escherichia coli expressed enzymes. Eur J Biochem 235: 372-381, 1996.
40. McCoubrey WK Jr, Cooklis MA, and Maines MD. The structure, organization and differential expression of the rat gene encoding biliverdin reductase. Gene 160: 235-240, 1995.
41. Messina JL, Standaert ML, Ishizuka T, Weinstock RS, and Farese RV. Role of protein kinase C in insulin's regulation of c-fos transcription. J Biol Chem 267: 9223-9228, 1992.
42. Miakotina OL and Snyder JM. TNF-alpha inhibits SP-A gene expression in lung epithelial cells via p38 MAPK. Am J Physiol Lung Cell Mol Physiol 283: L418-L427, 2002.
43. Miralem T, Hu Z, Torno MD, Lelli KM, and Maines MD. Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells. J Biol Chem 280: 17084-17092, 2005.
44. Mochly-Rosen D. Localization of protein kinases by anchoring proteins: a theme in signal transduction. Science 268: 247-251, 1995.
45. Mochly-Rosen D, Miller KG, Scheller RH, Khaner H, Lopez J, and Smith BL. p65 fragments, homologous to the C2 region of protein kinase C, bind to the intracellular receptors for protein kinase C. Biochemistry 31: 8120-8124, 1992.
46. Moscat J, Rennert P, and Diaz-Meco MT. PKCzeta at the crossroad of NF-kappaB and Jak1/Stat6 signaling pathways. Cell Death Differ 13: 702-711, 2006.
47. Newton AC. Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem Rev 101: 2353-2364, 2001.
48. Newton AC. Regulation of protein kinase C. Curr Opin Cell Biol 9: 161-167, 1997.
49. Nishizuka Y. Studies and perspectives of protein kinase C. Science 233: 305-312, 1986.
50. O'Neill LA. How Toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol 18: 3-9, 2006.
51. Parekh DB, Ziegler W, and Parker PJ. Multiple pathways control protein kinase C phosphorylation. EMBO J 19: 496-503, 2000.
52. Pawson T. Protein modules and signalling networks. Nature 373: 573-580, 1995.
53. Pawson T and Scott JD. Protein phosphorylation in signaling: 50 years and counting. Trends Biochem Sci 30: 286-290, 2005.
54. Pawson T and Scott JD. Signaling through scaffold, anchoring, and adaptor proteins. Science 278: 2075-2080, 1997.
55. Peng SL. Signaling in B cells via Toll-like receptors. Curr Opin Immunol 17: 230-236, 2005.
56. Rahman I, Antonicelli F, and MacNee W. Molecular mechanism of the regulation of glutathione synthesis by tumor necrosis factor-alpha and dexamethasone in human alveolar epithelial cells. J Biol Chem 274: 5088-5096, 1999.
57. Ron D, Chen CH, Caldwell J, Jamieson L, Orr E, and Mochly-Rosen D. Cloning of an intracellular receptor for protein kinase C: a homolog of the beta subunit of G proteins. Proc Natl Acad Sci U S A 91: 839-843, 1994.
58. Ron D and Mochly-Rosen D. An autoregulatory region in protein kinase C: the pseudoanchoring site. Proc Natl Acad Sci U S A 92: 492-496, 1995.
59. Salim M, Brown-Kipphut BA, and Maines MD. Human biliverdin reductase is autophosphorylated, and phosphorylation is required for bilirubin formation. J Biol Chem 276: 10929-10934, 2001.
60. Salinas M, Wang J, Rosa de Sagarra M, Martin D, Rojo AI, Martin-Perez J, Ortiz de Montellano PR, Cuadrado A. Protein Kinase Akt/PKB phosphorylates heme oxygenase-1 in vitro and in vivo. FEBS Lett 578: 90-94, 2004.
61. Saxton TM, Mark Henkemeyer, Stéphan Gasca, Randy Shen, Derrick J. Rossi, Fouad Shalaby, Gen-Sheng Feng, and Tony Pawson. Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2. EMBO J 16: 2352-2364, 1997.
62. Schluchter WM and Glazer AN. Characterization of cyanobacterial biliverdin reductase: conversion of biliverdin to bilirubin is important for normal phycobiliprotein biosynthesis. J Biol Chem 272: 13562-13569, 1997.
63. Shiga H, Yamane Y, Kubo M, Sakurai Y, Asou H, and Ito E. Differentiation of immature oligodendrocytes is regulated by phosphorylation of cyclic AMP-response element binding protein by a protein kinase C signaling cascade. J Neurosci Res 80: 767-776, 2005.
64. Shirai Y and Saito N. Activation mechanisms of protein kinase C: maturation, catalytic activation, and targeting. J Biochem (Tokyo) 132: 663-668, 2002.
65. Singleton JW and Laster L. Biliverdin reductase of guinea pig liver. J Biol Chem 240: 4780-4789, 1965.
66. Songyang Z, Shoelson SE, McGlade J, Olivier P, Pawson T, Bustelo XR, Barbacid M, Sabe H, Hanafusa H, Yi T. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol Cell Biol 14: 2777-2785, 1994.
67. Srivastava AK. High glucose-induced activation of protein kinase signaling pathways in vascular smooth muscle cells: a potential role in the pathogenesis of vascular dysfunction in diabetes (review). Int J Mol Med 9: 85-89, 2002.
68. Taylor SS, Radzio-Andzelm E, and Hunter T. How do protein kinases discriminate between serine/threonine and tyrosine? Structural insights from the insulin receptor protein-tyrosine kinase. FASEB J 9: 1255-1266, 1995.
69. Valledor AF, Xaus J, Comalada M, Soler C, and Celada A. Protein kinase Ce is required for the induction of mitogen-activated protein kinase phophatase-1 in lipopolysaccharide-stimulated macrophages. J Immunol 164: 29-37, 2000.
70. Wang J and de Montellano PR. The binding sites on human heme oxygenase-1 for cytochrome p450 reductase and biliverdin reductase. J Biol Chem 278: 20069-20076, 2003.
71. Whitby FG, Phillips JD, Hill CP, McCoubrey W, and Maines MD. Crystal structure of a biliverdin IXalpha reductase enzyme-cofactor complex. J Mol Biol 319: 1199-1210, 2002.
72. Wooten MW, Vandenplas ML, Seibenhener ML, Geetha T, Diaz-Meco MT. Nerve growth factor stimulates multisite tyrosine phosphorylation and activation of the atypical protein kinase Cs via src kinase pathway. Mol Cell Biol 21: 8414-8427, 2001.
73. Wyatt TA, Ito H, Veys TJ, and Spurzem JR. Stimulation of protein kinase C activity by tumor necrosis factor-alpha in bovine bronchial epithelial cells. Am J Physiol 273: L1007-1012, 1997.